Manatee Memorial Hospital Acute Care Hospital (Medicare Certified) Location: 206 2nd St E, Bradenton, Florida 34208 Ratings: Phone: (941) 746-5111 |
Blake Medical Center Acute Care Hospital (Medicare Certified) Location: 2020 59th St W, Bradenton, Florida 34209 Ratings: Phone: (941) 798-6110 |
Lakewood Ranch Medical Center Acute Care Hospital (Medicare Certified) Location: 8330 Lakewood Ranch Blvd, Bradenton, Florida 34202 Ratings: Phone: (941) 782-2100 |
Centerstone Of Florida Psychiatric Hospital (Medicare Certified) Location: 2020 26th Ave E, Bradenton, Florida 34208 Ratings:NA Phone: (941) 782-4299 |
Suncoast Behavioral Health Center Psychiatric Hospital (Medicare Certified) Location: 4480 51st St W, Bradenton, Florida 34210 Ratings:NA Phone: (941) 792-2222 |
News Archive
David H. Fater, CEO of Vicor Technologies, Inc., today announced that Andriy Batchinsky, MD, a researcher with the U.S. Army Institute of Surgical Research (USAISR), will present findings from a study of Vicor's PD2i VS™ (Vital Sign) at the American Heart Association's Resuscitation Science Symposium 2009 on November 14-15, 2009 in Orlando, Florida.
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European Hematology Association Congress in Amsterdam this week.
Studies by researchers at Wake Forest University School of Medicine have shown that blocking the NMDA receptor in immature rats leads to profound, rapid brain injury and disruption of auditory function as the animals mature.
Thirty years after AIDS was first described, there is still no effective vaccine against the HIV virus. Worldwide, roughly 33 million people are HIV-positive. Researchers are working to find out whether a HIV vaccine developed by a Norwegian biotech company can be administered nasally.
› Verified 1 days ago